Schonfeld Strategic Advisors »

Spero Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 20k 2.34
2025-06-30 $1.5M 511k 2.90
2018-09-30 $526k 50k 10.52

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Kraneshares Trust Csi Chi Internet (KWEB)
CRH Ord (CRH)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Ishares Tr China Lg-cap Etf (FXI)
Palantir Technologies Cl A (PLTR)
Unity Software (U)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Schonfeld Strategic Advisors

Top funds holding Spero Therapeutics

Pfizer
Vanguard Group
Vanguard Capital Management
Renaissance Technologies
Alphabet
Two Sigma Investments
Geode Capital Management
BlackRock
Citadel Advisors
Frigate Ventures
Susquehanna International
GSA Capital Partners
Vanguard Fiduciary Trust
State Street Corporation
Ionic Capital Management

View all funds holding Spero Therapeutics